Details
| Stereochemistry | MIXED |
| Molecular Formula | C22H28NO3.Br |
| Molecular Weight | 434.367 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 0 / 2 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
[Br-].CC[N+]1(C)CCCC(C1)OC(=O)C(O)(C2=CC=CC=C2)C3=CC=CC=C3
InChI
InChIKey=XEDCWWFPZMHXCM-UHFFFAOYSA-M
InChI=1S/C22H28NO3.BrH/c1-3-23(2)16-10-15-20(17-23)26-21(24)22(25,18-11-6-4-7-12-18)19-13-8-5-9-14-19;/h4-9,11-14,20,25H,3,10,15-17H2,1-2H3;1H/q+1;/p-1
| Molecular Formula | C22H27NO3 |
| Molecular Weight | 353.4547 |
| Charge | 0 |
| Count |
|
| Stereochemistry | MIXED |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 2 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
| Molecular Formula | BrH |
| Molecular Weight | 80.912 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: CHEMBL2094109 Sources: https://www.ncbi.nlm.nih.gov/pubmed/14349937 |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
Sources: https://www.ncbi.nlm.nih.gov/pubmed/13192610 |
Primary | Unknown Approved UseUnknown |
||
| Palliative | SINSPASMON Approved UseEffective in the treatment of peptic ulcer and coadjuvant in irritable bowel syndrome, spastic colon, mucosal colitis, acute enterocolitis, colic, pylorus spasm, regurgitation and other functional disorders of the gastrointestinal tract. |
PubMed
| Title | Date | PubMed |
|---|---|---|
| Normal pregnancy outcome following inadvertent exposure to rosiglitazone, gliclazide, and atorvastatin in a diabetic and hypertensive woman. | 2004-06 |
|
| The treatment index of JB 323 (piptal) in peptic ulcer. | 1957-01 |
|
| Peptic ulcer management with JB 323 (piptal) a new anticholinergic. | 1955-03 |
|
| Pharmacologic properties of N-ethyl-3-piperidyl benzilate methobromide (JB-323), a potent antispasmodic agent. | 1954-09 |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/13192610
for dog: orally active antispasmodic agent with an atropine-like action
Route of Administration:
Oral
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:38:08 GMT 2025
by
admin
on
Mon Mar 31 18:38:08 GMT 2025
|
| Record UNII |
JPX41DUS2B
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
CHEMBL1619528
Created by
admin on Mon Mar 31 18:38:08 GMT 2025 , Edited by admin on Mon Mar 31 18:38:08 GMT 2025
|
PRIMARY | |||
|
4347
Created by
admin on Mon Mar 31 18:38:08 GMT 2025 , Edited by admin on Mon Mar 31 18:38:08 GMT 2025
|
PRIMARY | |||
|
C170321
Created by
admin on Mon Mar 31 18:38:08 GMT 2025 , Edited by admin on Mon Mar 31 18:38:08 GMT 2025
|
PRIMARY | |||
|
100000081963
Created by
admin on Mon Mar 31 18:38:08 GMT 2025 , Edited by admin on Mon Mar 31 18:38:08 GMT 2025
|
PRIMARY | |||
|
m8843
Created by
admin on Mon Mar 31 18:38:08 GMT 2025 , Edited by admin on Mon Mar 31 18:38:08 GMT 2025
|
PRIMARY | Merck Index | ||
|
204-741-2
Created by
admin on Mon Mar 31 18:38:08 GMT 2025 , Edited by admin on Mon Mar 31 18:38:08 GMT 2025
|
PRIMARY | |||
|
202840
Created by
admin on Mon Mar 31 18:38:08 GMT 2025 , Edited by admin on Mon Mar 31 18:38:08 GMT 2025
|
PRIMARY | RxNorm | ||
|
652
Created by
admin on Mon Mar 31 18:38:08 GMT 2025 , Edited by admin on Mon Mar 31 18:38:08 GMT 2025
|
PRIMARY | |||
|
SUB09864MIG
Created by
admin on Mon Mar 31 18:38:08 GMT 2025 , Edited by admin on Mon Mar 31 18:38:08 GMT 2025
|
PRIMARY | |||
|
Pipenzolate bromide
Created by
admin on Mon Mar 31 18:38:08 GMT 2025 , Edited by admin on Mon Mar 31 18:38:08 GMT 2025
|
PRIMARY | |||
|
JPX41DUS2B
Created by
admin on Mon Mar 31 18:38:08 GMT 2025 , Edited by admin on Mon Mar 31 18:38:08 GMT 2025
|
PRIMARY | |||
|
DTXSID2023480
Created by
admin on Mon Mar 31 18:38:08 GMT 2025 , Edited by admin on Mon Mar 31 18:38:08 GMT 2025
|
PRIMARY | |||
|
125-51-9
Created by
admin on Mon Mar 31 18:38:08 GMT 2025 , Edited by admin on Mon Mar 31 18:38:08 GMT 2025
|
PRIMARY | |||
|
657306
Created by
admin on Mon Mar 31 18:38:08 GMT 2025 , Edited by admin on Mon Mar 31 18:38:08 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |